Only well-controlled CNS metastatic disease ie stable for at least 12 weeks after therapy (surgery, radiotherapy) for brain metastases. [clinicaltrials_resource:31a2fb0a59368761784d2f1c3a65a7b9]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Only well-controlled CNS metastatic disease ie stable for at least 12 weeks after therapy (surgery, radiotherapy) for brain metastases. [clinicaltrials_resource:31a2fb0a59368761784d2f1c3a65a7b9]
Bio2RDF identifier
31a2fb0a59368761784d2f1c3a65a7b9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:31a2fb0a59368761784d2f1c3a65a7b9
identifier
clinicaltrials_resource:31a2fb0a59368761784d2f1c3a65a7b9
title
Only well-controlled CNS metas ...... therapy) for brain metastases.
@en
type
label
Only well-controlled CNS metas ...... 2fb0a59368761784d2f1c3a65a7b9]
@en